vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
33.92
+1.68 (5.21%)
At close: Jun 17, 2026, 4:00 PM EDT
33.25
-0.67 (-1.98%)
After-hours: Jun 17, 2026, 5:00 PM EDT
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $420.93 million as of June 17, 2026. Its market cap has increased by 203.83% in one year.
Market Cap
420.93M
Enterprise Value
322.84M
1-Year Change
203.83%
Ranking
Category
Stock Price
$33.92
Market Cap Chart
Since July 31, 2015, vTv Therapeutics's market cap has increased from $78.12M to $420.93M, an increase of 438.79%. That is a compound annual growth rate of 16.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 420.92M | -15.17% |
| Dec 31, 2025 | 496.22M | 445.90% |
| Dec 31, 2024 | 90.90M | 288.02% |
| Dec 29, 2023 | 23.43M | -56.62% |
| Dec 30, 2022 | 54.01M | -18.92% |
| Dec 31, 2021 | 66.61M | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Forte Biosciences | 419.07M |
| Monopar Therapeutics | 417.67M |
| Prelude Therapeutics | 416.55M |
| Adlai Nortye | 402.00M |
| Ocugen | 399.46M |
| Autolus Therapeutics | 396.55M |
| Eupraxia Pharmaceuticals | 393.20M |
| Century Therapeutics | 393.17M |